Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B with Inhibitor”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Testing effectiveness (Phase 2)UnknownNCT02463591
What this trial is testing

Reversal of Dabigatran With Prothrombin Complex Concentrate

Who this might be right for
Drug Action Reversal
University Medical Center Groningen 12
Testing effectiveness (Phase 2)Ended earlyNCT05789537
What this trial is testing

SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors

Who this might be right for
Hemophilia B with InhibitorHemophilia B
ApcinteX Ltd 3
Not applicableStudy completedNCT03619863
What this trial is testing

ATHN 7: Hemophilia Natural History Study

Who this might be right for
Hemophilia A With InhibitorHaemophilia A Without InhibitorHemophilia B With Inhibitor+1 more
American Thrombosis and Hemostasis Network 395
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Large-scale testing (Phase 3)Study completedNCT00868530
What this trial is testing

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

Who this might be right for
Hemophilia A
Pfizer 53
Testing effectiveness (Phase 2)Study completedNCT05619926
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 32
Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Very early researchUnknownNCT06125756
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Affiliated Hospital of Guangdong Medical University 9
Early research (Phase 1)WithdrawnNCT03996486
What this trial is testing

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

Who this might be right for
Hemophilia
Bayer
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT00866606
What this trial is testing

Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 35
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 188
Early research (Phase 1)Study completedNCT04747964
What this trial is testing

A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 16
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Next Page